The role of histologic remission as disease clearance: Emerging treat-to-target in pediatric ulcerative colitis

Authors: Kim, Yoon Zi; Kim, Eun Sil; Kwon, Yiyoung; Jeong, Tae Jong; Choe, Yon Ho; Kim, Mi Jin

Source journal: Journal of pediatric gastroenterology and nutrition (2026-11-17)

DOI: 10.1002/jpn3.70685

Abstract

OBJECTIVES: While clinical and endoscopic remission (ER) are established therapeutic targets in ulcerative colitis (UC), endoscopic healing may not fully reflect residual microscopic inflammation. Histologic remission (HR) has been proposed as a deeper marker of disease control and a potential predictor of long-term outcomes. We evaluated whether HR predicts relapses in pediatric UC patients who achieved ER. METHODS: This multicenter retrospective cohort study included pediatric patients with UC ( /=3, corticosteroid initiation, requiring treatment escalation, UC-related hospitalization, colectomy or death. Relapse-free survival was analyzed using Kaplan-Meier estimates and Cox proportional hazards models. RESULTS: Among 111 pediatric UC patients with ER, 35 (31.5%) achieved HR. Patients with HR showed significantly improved relapse-free survival than non-HR (log-rank p = 0.015). Multivariable Cox regression demonstrated that both ER (MES 0 vs. 1; hazard ratio 0.57, 95% confidence interval (CI) 0.28-0.94, p = 0.032) and HR (hazard ratio 0.39, 95% CI 0.17-0.91, p = 0.030) independently predicted reduced relapse risk. Notably, even among patients with ER, those with a Nancy index of 0 had superior relapse-free survival versus a score of 1 (p = 0.008). CONCLUSIONS: HR was achieved in only one-third of pediatric patients with UC with ER but was strongly associated with reduced relapse, supporting HR as a treatment target beyond ER.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.